Olfactory acuity based on Brief Smell Identification Test (BSIT?) in migraine patients with and without aura: A cross-sectional, controlled study

Basit Öğe Kaydı
dc.contributor.authorKandemir, Süheyla
dc.contributor.authorPamuk, A. Erim
dc.contributor.authorHabipoğlu, Yasin
dc.contributor.authorÖzel, Gökçe
dc.contributor.authorBayar Muluk, Nuray
dc.contributor.authorKılıç, Rahmi
dc.date.accessioned2025-01-21T16:28:07Z
dc.date.available2025-01-21T16:28:07Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective: The aim of this study was to evaluate olfactory acuity in migraine patients with and without aura (MwA and MwoA) Material and methods: The study included 30 MwA patients, 30 MwoA patients, and 30 age- and gender-matched controls. Demographic features and odor-related symptoms (osmophobia, odor offensiveness, and odor-triggered attack status) were noted. Olfactory acuity was measured using the Brief Smell Identification Test (BSIT®), a 12-item derivative of the University of Pennsylvania Smell Identification Test (UPSIT®). BSIT® scores were compared between the migraine patients and controls. Results: The mean BSIT® score did not differ significantly between the MwA patients (8.7 ± 0.9) and MwoA (9.17 ± 0.9) patients (P = 0.094); however, the mean score in the control group was higher (10.4 ± 0.6) than in the MwA and MwoA patients (P < 0.001). The mean BSIT® score did not differ significantly between patients with and without odor-triggered migraine attacks (9 ± 0.9 and 8.8 ± 0.8, respectively) (P = 0.4). Osmophobia and odor-triggered attacks were more common in the MwA patients than in the MwoA patients (odor-triggered attacks: 66% vs. 40% [P = 0.04]; osmophobia: 76.6% vs. 60% [P = 0.16]) Conclusion: Olfactory acuity is lower during attack-free periods in migraine patients, as compared to controls. Migraine aura status does not affect olfactory acuity. Odor-triggered attacks, osmophobia, and offensive odors between attacks were more common in the MwA patients than in the MwoA patients. © 2021
dc.identifier.doi10.1016/j.anl.2021.11.014
dc.identifier.endpage617
dc.identifier.issn0385-8146
dc.identifier.issue4
dc.identifier.pmid34930631
dc.identifier.scopus2-s2.0-85121454807
dc.identifier.scopusqualityQ2
dc.identifier.startpage613
dc.identifier.urihttps://doi.org/10.1016/j.anl.2021.11.014
dc.identifier.urihttps://hdl.handle.net/20.500.12587/23487
dc.identifier.volume49
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofAuris Nasus Larynx
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectAura; Brief Smell Identification Test; BSIT; Migraine; Olfaction; Smell tests
dc.titleOlfactory acuity based on Brief Smell Identification Test (BSIT?) in migraine patients with and without aura: A cross-sectional, controlled study
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu